We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK to Pay States $40 Million Over Cidra Plant GMP Complaint
GSK to Pay States $40 Million Over Cidra Plant GMP Complaint
July 5, 2011
GlaxoSmithKline (GSK) has agreed to pay a total of $40.75 million to 37 states and the District of Columbia to address allegations of substandard drug manufacturing processes at its former manufacturing facility in Cidra, Puerto Rico.